Cardiovascular safety of rofecoxib (Vioxx): lessons learned and unanswered questions
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- November 2004
has subject area
- 11 Medical and Health Sciences (FoR)
- 17 Psychology and Cognitive Sciences (FoR)
- Cardiovascular Diseases (MeSH)
- Cyclooxygenase Inhibitors (MeSH)
- General & Internal Medicine (Science Metrix)
- Humans (MeSH)
- Lactones (MeSH)
- Product Surveillance, Postmarketing (MeSH)
- Risk Assessment (MeSH)
- Sulfones (MeSH)
published in
- Medical Journal of Australia Journal